Skip to main content
Top
Published in: Familial Cancer 3/2009

01-09-2009

Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum

Authors: Mef Nilbert, Christina Therkildsen, Anja Nissen, Måns Åkerman, Inge Bernstein

Published in: Familial Cancer | Issue 3/2009

Login to get access

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is primarily linked to colorectal and endometrial cancer, but is associated with a broad tumor spectrum. Though not formally part of the syndrome, occasional sarcomas have been reported in individuals with HNPCC. We used the national Danish HNPCC-register to identify HNPCC families in which sarcomas had been diagnosed. Fourteen sarcomas were identified in families with mutations in MSH2, MSH6, and MLH1. The median age at sarcoma diagnosis was 43 (15–74) years. Soft tissue sarcomas predominated followed by uterine sarcomas and eight histopathological subtypes were represented with recurrent diagnoses of liposarcoma, leiomyosarcoma, and carcinosarcoma. Tumor tissue from eight cases was available for analysis of mismatch-repair (MMR) status using immunohistochemical staining and analysis of microsatellite instability, which revealed MMR defects in six of the eight tumors investigated. This suggests that sarcomas may be part of the HNPCC tumor spectrum and that colorectal cancer should be considered in the family history of sarcoma patients.
Literature
1.
go back to reference Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA mismatch-repair genes. Int J Cancer 81:214–218. doi:10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-LPubMedCrossRef Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA mismatch-repair genes. Int J Cancer 81:214–218. doi:10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-LPubMedCrossRef
2.
go back to reference Barrow E, Alduaij W, Robinson L et al (2008) Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumor distribution. A report of 121 families with proven mutations. Clin Genet 74:233–242PubMedCrossRef Barrow E, Alduaij W, Robinson L et al (2008) Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumor distribution. A report of 121 families with proven mutations. Clin Genet 74:233–242PubMedCrossRef
5.
go back to reference Fletcher CDM, Unni KK, Mertens F (eds) (2002) Pathology and genetics of tumours of soft tissue and bone. World Health Organization Classification of Tumours. IARC Press, Lyon Fletcher CDM, Unni KK, Mertens F (eds) (2002) Pathology and genetics of tumours of soft tissue and bone. World Health Organization Classification of Tumours. IARC Press, Lyon
9.
go back to reference Sijmons R, Hofstra R, Hollema H et al (2000) Inclusion of malignant fibrous histiocytoma in the tumor spectrum associated with hereditary non-polyposis colorectal cancer. Genes Chrom Cancer 29:353–355. doi:10.1002/1098i264(2000)9999:9999<::AID-GCC1042>3.0.CO;2-TPubMedCrossRef Sijmons R, Hofstra R, Hollema H et al (2000) Inclusion of malignant fibrous histiocytoma in the tumor spectrum associated with hereditary non-polyposis colorectal cancer. Genes Chrom Cancer 29:353–355. doi:10.1002/1098i264(2000)9999:9999<::AID-GCC1042>3.0.CO;2-TPubMedCrossRef
10.
go back to reference Medina Arana V, Barrios del Pino Y, Garcia-Castro C et al (2002) Highly aggressive leiomyosarcoma associated with Lynch II syndrome: increasing the range of extracolonic cancers related with hereditary non-polyposis colonic cancer. Ann Oncol 13:807–808. doi:10.1093/annonc/mdf163 PubMedCrossRef Medina Arana V, Barrios del Pino Y, Garcia-Castro C et al (2002) Highly aggressive leiomyosarcoma associated with Lynch II syndrome: increasing the range of extracolonic cancers related with hereditary non-polyposis colonic cancer. Ann Oncol 13:807–808. doi:10.​1093/​annonc/​mdf163 PubMedCrossRef
11.
go back to reference South SA, Hutton M, Farrell C, Mhawech-Fauceglia P, Rodabaugh KJ (2007) Uterine carcinosaroma associated with hereditary nonpolyposis colorectal cancer. Obstet Gynecol 110:543–545PubMed South SA, Hutton M, Farrell C, Mhawech-Fauceglia P, Rodabaugh KJ (2007) Uterine carcinosaroma associated with hereditary nonpolyposis colorectal cancer. Obstet Gynecol 110:543–545PubMed
13.
go back to reference Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116:1453–1456. doi:10.1016/S0016-5085(99)70510-X PubMedCrossRef Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116:1453–1456. doi:10.​1016/​S0016-5085(99)70510-X PubMedCrossRef
14.
go back to reference Lin KM, Shashidharan M, Ternent CA et al (1998) Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 41:428–433. doi:10.1007/BF02235755 PubMedCrossRef Lin KM, Shashidharan M, Ternent CA et al (1998) Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 41:428–433. doi:10.​1007/​BF02235755 PubMedCrossRef
15.
go back to reference Nilbert M, Wikman FP, Hansen TV et al (2008) Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population. Fam Cancer. doi:10.1007/s10689-008-9199-3 Nilbert M, Wikman FP, Hansen TV et al (2008) Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population. Fam Cancer. doi:10.​1007/​s10689-008-9199-3
16.
Metadata
Title
Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum
Authors
Mef Nilbert
Christina Therkildsen
Anja Nissen
Måns Åkerman
Inge Bernstein
Publication date
01-09-2009
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2009
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-008-9230-8

Other articles of this Issue 3/2009

Familial Cancer 3/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine